In primary human colon cancer cells, pCan1 and pCan2, A1874 (100 nM) treatment led to robust degradation of BRD4 protein (Fig. 3a) without affecting BRD4 mRNA expression (Fig. 3b). Here, BRD4 is linked to malignant colon neoplasm.